Epicardial fat and sleep apnea: perspective mechanisms, diagnostics, and therapeutics
Obesity and Endocrinology · 29.09.2025 · 1 (2)
DOI: 10.1093/obendo/wjaf009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity and Endocrinology, online erschienen am 04.10.2025. Verfasst von Ron T Varghese und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Miller School of Medicine, University of Miami, Department of Internal Medicine.
Abstract (Originalsprache)
Obesity is a risk factor for the development of obstructive sleep apnea (OSA). The role of visceral adiposity in contributing to OSA has been highlighted in this review. The use of noninvasive methods of measurement of visceral adiposity, including epicardial adipose tissue (EAT) thickness, offers a unique opportunity to elucidate changes in visceral adiposity in the setting of OSA. The role and impact of newer medications, including incretin-based therapy, on EAT thickness and their role in the management of OSA have also been highlighted.
Förderung
- Miller School of Medicine, University of Miami
- Department of Internal Medicine
Zitieren
APA
Varghese, R. T., Akurati, S., & Iacobellis, G. (2025). Epicardial fat and sleep apnea: perspective mechanisms, diagnostics, and therapeutics. Obesity and Endocrinology, 1(2). https://doi.org/10.1093/obendo/wjaf009
Vancouver
Varghese RT, Akurati S, Iacobellis G. Epicardial fat and sleep apnea: perspective mechanisms, diagnostics, and therapeutics. Obesity and Endocrinology. 2025;1(2). doi:10.1093/obendo/wjaf009
BibTeX
@article{Varghese2025,
author = {Varghese, Ron T and Akurati, Sneha and Iacobellis, Gianluca},
title = {Epicardial fat and sleep apnea: perspective mechanisms, diagnostics, and therapeutics},
journal = {Obesity and Endocrinology},
year = {2025},
volume = {1},
number = {2},
doi = {10.1093/obendo/wjaf009}
}
EUVIMED